Systolic BP Target
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 21, 2025 -- Most older adults in the Systolic Blood Pressure Intervention Trial (SPRINT) have a net benefit favoring a systolic blood pressure (BP) target <120 mm Hg, according to a study published online Feb. 18 in the Journal of the American Geriatrics Society.
Mitra S. Jamshidian, M.D., from the University of California San Francisco, and colleagues estimated the individualized net benefit of intensive BP lowering among community-dwelling older adults in SPRINT. Cox models were internally validated to predict an absolute difference in risk between treating to a systolic BP target <120 versus <140 mm Hg among 5,143 SPRINT participants aged 65 years and older. Net benefits of treatment were compared across categories of age, SPRINT-derived frailty status, and polypharmacy.
The researchers found that the median net benefit was 4 percentage points from intensive BP lowering when simulating preferences for participants who view the benefits of BP lowering as much more important than treatment-related harms, and 100 percent had a positive net benefit favoring intensive BP lowering. The median net benefit was 1 percentage point when simulating benefits and harms to have similar, intermediate importance, and 85 percent had a positive net benefit. Despite experiencing more harm in both simulations, participants with advanced age and frailty had greater net benefits from intensive BP lowering; when benefits were viewed as much more important than harms, those with polypharmacy had greater net benefits.
"The evidence from SPRINT can be translated to each person using individualized risks and preferences, and that consideration of advanced age, frailty, and polypharmacy alone should not deter clinicians from recommending intensive BP lowering," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Many ADHD Medications Lead to Increases in Blood Pressure and Heart Rate
MONDAY, April 21, 2025 -- Many pharmacological treatments for attention-deficit/hyperactivity disorder (ADHD) lead to increases in hemodynamic signs, including blood pressure and...
Early Pregnancy BP Trajectories Linked to New-Onset HTN Years Later
THURSDAY, April 17, 2025 -- Early pregnancy blood pressure (BP) trajectories are associated with new-onset hypertension up to 14 years later, according to a study published online...
Relaxation, Stress Management Have Short-Term Benefit for Hypertension
FRIDAY, April 11, 2025 -- Relaxation and stress management techniques have short-term beneficial effects for people with hypertension, according to a systematic review and network...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.